Oesophageal cancer is a gastrointestinal malignancy with insidious onset and poor prognosis. The disease predominantly affects the older age groups with pick incidence between 60 to 70 years of age. The total number of oesophageal cancer patients available for the study within the stipulated time was 43. Among them 60.47% patients were male and 39.53% patients were female, 06.98% belonged to age group 31-40, 16.28% belonged to age group 41-50, 37.21% belonged to age group 51-60, 23.25% belonged to age group 61-70 and 16.28% patients were >70 years of age. Mean age was 59.95 years ± 12.63 SD. In our study, 33.3% survived ≤3 months, 09.1% 4-6 months, 15.2 % 7-9 months, 06.1% 10-12 months, 27.2% 13-24 months and 09.1% >24 months. Among the expired patients, 09.10% got curative treatment and rest of 90.90% got palliative treatment. Those who got curative treatment 66.7% survived 13-24 months and 33.3% > 24 months. Those who got palliative treatment 36.7% survived ≤3 months, 10.0% 4-6 months, 06.7% 10-12 months and 30.0% 13-24 months. Overall median survival was 08 months, for curative treatment 18 months and for palliative treatment 07 months.
Introduction
Gastrointestinal tract is the most common site for malignancy and second most common cause of cancer related mortality in the United States. 1 The common malignancy in gastroenterology are carcinoma oesophagus, carcinoma stomach, colorectal cancer, hepatocellular carcinoma, carcinoma pancreas and cholangiocarcinoma. The incidence of these cancers of different sites differs significantly by geographic region and race. Age of presentation also varies from country to country. Oesophageal cancer is a gastrointestinal malignancy with insidious onset and poor prognosis. The disease predominantly affects the older age groups with pick incidence between 60 to 70 years of age. It occurs frequently within a geographic region extending from the southern shore of the Caspian Sea on the west to northern China on the east and encompassing parts of Iran, Central Asia, Afghanistan, Siberia and Mongolia. 2 Oesophageal cancer is the seventh most common cause of cancer related deaths in man in the United States and has ranked among the top ten causes of cancer related death worldwide. 3 In USA, the 5 years survival rates were 15.8% for carcinoma oesophagus. 4 But in India the 5 year relative survival rates were 11.8% for carcinoma oesophagus. 5 Cancer in oesophagus is extremely lethal malignancy. 6 
Objectives
To determine the factors affecting the survival trend of carcinoma oesophagus.
Material and Methods
It was a prospective cross sectional study done in the Department of Gastroenterology, BSMMU,
Dhaka from16
th April 2010 to 15 th October 2011. Cases were selected frompatientswho were admitted in the department of Gastroenterology, Hepatology, Medicine, Surgery and Oncology as well as patients of oesophageal cancers attending outpatient department of BSMMU.
Result
The total number of cases available for the study within the stipulated time was 43. Among them 26 (60.47%) patients were male and 17 (39.53%) patients were female.
Fig.1: Male and female ratio of oesophageal cancer patients
Among 43 patients, 0 patient belonged to age group ≤ 20, 0 belonged to age group 21-30, 03 belonged to age group 31-40, 07 belonged to age group 41-50, 16 belonged to age group 51-60, 10 belonged to age group 61-70 and 07 patients were >70 years of age. Mean age was 59.95 years ± 12.63 SD. Cheung MC et.al.found two thirds (66%) of the patients had squamous cell carcinoma, 34% of the patients had a diagnosis of adenocarcinoma. At the time of diagnosis, about half of the patients with either type of cancer had metastatic disease. 9 In our study, we found 02.33% cancer involved in the upper part, 46.51% in the middle part and 51.16% in the lower part of oesophagus. 65.12% patients had squamous cell carcinoma and 34.88% had adenocarcinoma. 74.42% patients presented with metastasis (lymph node and other organ) during diagnosis.
In our study, duration between onset of symptoms and date of confirmatory diagnosis were 55.8% ≤3 months, 23.3% 4-6 months, 09.3% 7-9 months, 07.0% 10-12 months and 04.6% >12 months. Mean duration of diagnosis was 05 months. 16.28% lost follow up during the study period and who were in regular follow up, 08.33% was alive and 91.67% expired during the follow up period.
Cheung MC et.al.found the survival rate for those with SCC was 1.1 years and for those with adenocarcinomas was 8 months. Most of the patients who received chemotherapy and radiotherapy had a diagnosis of squamous cell carcinoma, while those who had surgery were mostly adenocarcinoma cases. 10 In our study, 33.3% survived ≤3 months, 09.1% 4-6 months, Reported overall 5 years survival is 10-15% worldwide. 11 In India, 5 years survival in carcinoma oesophagus is 11.8% and 1 year 34%. 12 In Pakistan the median survival is 7 months. In Iran median survival is 9 months. If we consider worldwide 5 years survival trend, Bangladesh record is not adequate and median survival is low due to some factors like early age of presentation, more time required for confirmatory diagnosis, most of the patient diagnosed at advance stage, lack of facility for curative as well as palliative treatment and loss of follow up.
Conclusion
This study was done keeping in mind to estimate the survival trend of the patients who had malignancy involvingoesophagus. The current study identified most of the patients of carcinoma oesophagusare died earlier than expected due to a variety of reasons including early age of presentation, delayed confirmatory diagnosis, diagnosis of the cancer at advance stage, unavailability of curative treatment, financial problem to take curative as well as palliative treatment and loss of follow up. The patients who received curative treatment are having more chance of better survival.
